Sima Ferman

1.6k total citations
47 papers, 780 citations indexed

About

Sima Ferman is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Sima Ferman has authored 47 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Pediatrics, Perinatology and Child Health and 14 papers in Oncology. Recurrent topics in Sima Ferman's work include Sarcoma Diagnosis and Treatment (14 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). Sima Ferman is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Childhood Cancer Survivors' Quality of Life (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). Sima Ferman collaborates with scholars based in Brazil, Spain and Netherlands. Sima Ferman's co-authors include Beatriz de Camargo, Rejane de Souza Reis, Marceli de Oliveira Santos, Maria S. Pombo‐de‐Oliveira, Marise Souto Rebelo, Soledad Gallego, Ilaria Zanetti, Heidi Glosli, Johannes H. M. Merks and Daniel Orbach and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sima Ferman

43 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sima Ferman Brazil 16 273 270 154 150 148 47 780
Laura Botta Italy 15 255 0.9× 288 1.1× 100 0.6× 195 1.3× 106 0.7× 55 791
Brijesh Arora India 17 205 0.8× 181 0.7× 178 1.2× 226 1.5× 128 0.9× 67 1.0k
J E Kingston United Kingdom 13 160 0.6× 172 0.6× 124 0.8× 200 1.3× 137 0.9× 27 806
P.N. Plowman United Kingdom 20 257 0.9× 253 0.9× 146 0.9× 93 0.6× 239 1.6× 55 1.1k
Amalia Schiavetti Italy 19 365 1.3× 140 0.5× 387 2.5× 165 1.1× 188 1.3× 66 839
Strong Lc United States 3 317 1.2× 200 0.7× 68 0.4× 122 0.8× 122 0.8× 4 606
Jeffrey Davis Canada 17 323 1.2× 152 0.6× 152 1.0× 90 0.6× 207 1.4× 41 1.0k
Chitose Ogawa Japan 13 135 0.5× 170 0.6× 132 0.9× 110 0.7× 114 0.8× 79 674
Xavier Panis France 14 360 1.3× 250 0.9× 74 0.5× 185 1.2× 172 1.2× 27 850
Ann L. Hartley United Kingdom 17 190 0.7× 365 1.4× 299 1.9× 253 1.7× 103 0.7× 27 818

Countries citing papers authored by Sima Ferman

Since Specialization
Citations

This map shows the geographic impact of Sima Ferman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sima Ferman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sima Ferman more than expected).

Fields of papers citing papers by Sima Ferman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sima Ferman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sima Ferman. The network helps show where Sima Ferman may publish in the future.

Co-authorship network of co-authors of Sima Ferman

This figure shows the co-authorship network connecting the top 25 collaborators of Sima Ferman. A scholar is included among the top collaborators of Sima Ferman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sima Ferman. Sima Ferman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ferman, Sima, et al.. (2024). Late dental and bone alterations in patients after orbital rhabdomyosarcoma treatment. Supportive Care in Cancer. 32(10). 642–642.
3.
Mandeville, Henry, Gianni Bisogno, Véronique Minard‐Colin, et al.. (2024). Localized incompletely resected standard risk rhabdomyosarcoma in children and adolescents: Results from the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 trial. Cancer. 130(23). 4071–4084. 3 indexed citations
4.
Chisholm, Julia, Reineke A. Schoot, Alison Cameron, et al.. (2023). Outcomes in lung-only metastatic rhabdomyosarcoma: An analysis of data from the European paediatric Soft tissue sarcoma Study Group MTS 2008 study. SHILAP Revista de lepidopterología. 2. 100018–100018. 1 indexed citations
5.
Bisogno, Gianni, Véronique Minard‐Colin, Ilaria Zanetti, et al.. (2023). Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study. Journal of Clinical Oncology. 41(13). 2342–2349. 21 indexed citations
6.
7.
Bonvicino, Cibele Rodrigues, Patrícia Ashton‐Prolla, Sidnei Epelman, et al.. (2022). Diverse mutational spectrum in the 13q14 chromosomal region in a Brazilian cohort of retinoblastoma. Experimental Eye Research. 224. 109211–109211. 2 indexed citations
8.
Nobre, Gustavo Cattelan, et al.. (2021). Root cause analysis of safety incidents in antineoplastic use in children. Revista Brasileira de Enfermagem. 77(suppl 3). e20210139–e20210139. 1 indexed citations
9.
Bergmann, Anke, et al.. (2021). Malnutrition at diagnosis and throughout therapy in pediatric patients with solid tumors: A single‐institution study in a developing country. Pediatric Blood & Cancer. 68(11). e29317–e29317. 10 indexed citations
10.
Ferman, Sima, et al.. (2021). Qualidade de vida de crianças e adolescentes com câncer: Estudos que aplicaram o PedsQL 3.0 Cancer Module. Research Society and Development. 10(8). e52710817570–e52710817570. 1 indexed citations
11.
Ferman, Sima, et al.. (2019). Preventing treatment abandonment for children with solid tumors: A single‐center experience in Brazil. Pediatric Blood & Cancer. 66(7). e27724–e27724. 9 indexed citations
12.
Bisogno, Gianni, Gian Luca De Salvo, Christophe Bergeron, et al.. (2019). Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology. 20(11). 1566–1575. 149 indexed citations
13.
Fernandes, Ricardo Ribeiro Alves, Cid Manso de Mello Vianna, Renata Leborato Guerra, et al.. (2019). Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume–Based Analysis. Value in Health Regional Issues. 20. 122–128. 7 indexed citations
14.
Reis, Rejane de Souza, et al.. (2016). Cancer Incidence Among Adolescents and Young Adults (15 to 29 Years) in Brazil. Journal of Pediatric Hematology/Oncology. 38(3). e88–e96. 16 indexed citations
15.
Milito, Cristiane, Elen Oliveira, Samuel Dekermacher, et al.. (2013). Contribution of Multiparameter Flow Cytometry Immunophenotyping to the Diagnostic Screening and Classification of Pediatric Cancer. PLoS ONE. 8(3). e55534–e55534. 45 indexed citations
16.
Ferman, Sima, et al.. (2011). Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma. Pediatric Blood & Cancer. 59(1). 39–43. 23 indexed citations
17.
Ferman, Sima, et al.. (2006). Survival analysis and body mass index in pediatric patients wirh rhabdomyosarcoma: 18 years experience at the brazilian national cancer institute. Pediatric Blood & Cancer. 47(4). 451. 1 indexed citations
18.
Ferman, Sima, et al.. (2006). O diagnóstico tardio de rabdomiossarcoma. 109–116.
19.
Vargas, Fernando Regla, et al.. (2006). A molecular study of first and second RB1 mutational hits in retinoblastoma patients. Cancer Genetics and Cytogenetics. 167(1). 43–46. 16 indexed citations
20.
Braggio, Esteban, Cibele Rodrigues Bonvicino, Fernando Vargas, et al.. (2004). Identification of three novel RB1 mutations in Brazilian patients with retinoblastoma by “exon by exon” PCR mediated SSCP analysis. Journal of Clinical Pathology. 57(6). 585–590. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Botta Breakdown of academic impact, for papers by Brijesh Arora Breakdown of academic impact, for papers by J E Kingston Breakdown of academic impact, for papers by P.N. Plowman Breakdown of academic impact, for papers by Amalia Schiavetti Breakdown of academic impact, for papers by Strong Lc Breakdown of academic impact, for papers by Jeffrey Davis Breakdown of academic impact, for papers by Chitose Ogawa Breakdown of academic impact, for papers by Xavier Panis Breakdown of academic impact, for papers by Ann L. Hartley
Rankless by CCL
2026